FBTAX
Price
$30.03
Change
+$0.26 (+0.87%)
Updated
Aug 15 closing price
Net Assets
1.4B
LHCFX
Price
$19.40
Change
+$0.12 (+0.62%)
Updated
Aug 15 closing price
Net Assets
7.55M
Interact to see
Advertisement

FBTAX vs LHCFX

Header iconFBTAX vs LHCFX Comparison
Open Charts FBTAX vs LHCFXBanner chart's image
Fidelity Advisor Biotechnology A
Price$30.03
Change+$0.26 (+0.87%)
VolumeN/A
Net Assets1.4B
Lord Abbett Health Care F
Price$19.40
Change+$0.12 (+0.62%)
VolumeN/A
Net Assets7.55M
FBTAX vs LHCFX Comparison Chart in %
Loading...
View a ticker or compare two or three
VS
FBTAX vs. LHCFX commentary
Aug 18, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is FBTAX is a Buy and LHCFX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
FBTAX has more cash in the bank: 1.4B vs. LHCFX (7.55M). FBTAX pays higher dividends than LHCFX: FBTAX (2.74) vs LHCFX (0.48). FBTAX was incepted earlier than LHCFX: FBTAX (25 years) vs LHCFX (6 years). LHCFX (3.19) is less costly to investors than FBTAX (0.96). LHCFX is a more actively managed with annual turnover of: 88.00 vs. FBTAX (73.00). FBTAX (0) and LHCFX (0) have matching initial minimum investment requirements. FBTAX annual gain was more profitable for investors over the last year : -3.79 vs. LHCFX (-4.73). LHCFX return over 5 years is better than : 5.77 vs. FBTAX (1.58).
FBTAXLHCFXFBTAX / LHCFX
Total Expense Ratio0.960.78123%
Annual Report Gross Expense Ratio0.963.1930%
Fund Existence25 years6 years-
Gain YTD10.3640.000-
Front Load6%N/A-
Min. Initial Investment00-
Min. Initial Investment IRAN/AN/A-
Net Assets1.4B7.55M18,535%
Annual Yield % from dividends2.740.48569%
Returns for 1 year-3.79-4.7380%
Returns for 3 years22.337.88283%
Returns for 5 years1.585.7727%
Returns for 10 years4.97N/A-
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
OTLC0.05N/A
+1.64%
Oncotelic Therapeutics, Inc.
APMSF30.50N/A
N/A
Aperam S.A.
AILIM76.25N/A
N/A
Ameren Illinois Company
GRPTF19.28N/A
N/A
Getlink SE
MLGF20.16-0.02
-0.10%
Malaga Financial Corp.